Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
831 studies found for:    "Cystic fibrosis"
Show Display Options
Rank Status Study
21 Completed Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)
Condition: Cystic Fibrosis
Intervention: Drug: Fluticasone or placebo
22 Unknown  Transfer Impedance in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
23 Recruiting Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified
Condition: Cystic Fibrosis
Interventions: Drug: Ceftazidime;   Drug: Tobramycin
24 Completed Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
25 Completed Hydroxychloroquine in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: hydroxychloroquine
26 Completed SD Cystic Fibrosis Study
Condition: Cystic Fibrosis
Intervention: Drug: SB656933
27 Completed Extension Study of Arikayce in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa Infection
Condition: Cystic Fibrosis
Intervention: Drug: Liposomal amikacin for inhalation
28 Completed Multidose Safety and Tolerability Study of (Arikace™) for Inhalation In Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention: Drug: Arikace™
29 Completed Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner
Condition: Cystic Fibrosis
Intervention:
30 Completed Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation
Condition: Cystic Fibrosis
Intervention:
31 Terminated Airway Secretion Clearance in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Device: High frequency chest wall oscillation;   Device: Oscillatory Positive Expiratory Pressure;   Other: PD&P: Postural drainage and percussion
32 Completed Inhaled Bicarbonate Therapy in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Procedure: sodium bicarbonate
33 Completed
Has Results
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID);   Drug: Placebo two times a day (BID)/three times a day (TID)
34 Terminated Oxygen Therapy in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Other: Air - oxygen;   Other: Oxygen - Air
35 Completed PTC124 for Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: PTC124
36 Completed
Has Results
International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg three times a day (TID);   Drug: Placebo three times a day (TID)
37 Completed
Has Results
Absorptive Clearance in the Cystic Fibrosis Airway
Condition: Cystic Fibrosis
Intervention: Other: Technetium [Tc-99m] sulfur colloid and Indium [In-111] DTPA
38 Unknown  Cystic Fibrosis (CF) Exacerbation and Insulin Treatment
Conditions: Cystic Fibrosis;   Impaired Glucose Tolerance;   Pulmonary Exacerbation
Interventions: Drug: novorapid / humalog short acting insulin;   Drug: Novo Rapid Insulin (Novonordisk)
39 Not yet recruiting Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
Condition: Cystic Fibrosis
Interventions: Drug: Oral Aztreonam;   Drug: Nasal Aztreonam;   Drug: Nasal Placebo
40 Completed Volatile Organic Compounds in Cystic Fibrosis
Conditions: Cystic Fibrosis;   Pseudomonas Aeruginosa
Intervention: Other: Cystic Fibrosis patients

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years